USNA - USANA Health Sciences, Inc.

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
1.55B
Enterprise Value 3
1.33B
Trailing P/E
15.46
Forward P/E 1
15.61
PEG Ratio (5 yr expected) 1
1.86
Price/Sales (ttm)
1.38
Price/Book (mrq)
4.17
Enterprise Value/Revenue 3
1.18
Enterprise Value/EBITDA 6
7.57

Trading Information

Stock Price History

Beta (3Y Monthly) 0.46
52-Week Change 3-33.30%
S&P500 52-Week Change 38.78%
52 Week High 3125.61
52 Week Low 358.30
50-Day Moving Average 369.63
200-Day Moving Average 372.64

Share Statistics

Avg Vol (3 month) 3202.16k
Avg Vol (10 day) 3146.85k
Shares Outstanding 522.26M
Float 10.57M
% Held by Insiders 142.41%
% Held by Institutions 153.83%
Shares Short (Sep 30, 2019) 41.56M
Short Ratio (Sep 30, 2019) 49.34
Short % of Float (Sep 30, 2019) 411.63%
Short % of Shares Outstanding (Sep 30, 2019) 47.00%
Shares Short (prior month Aug 30, 2019) 41.62M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/2
Last Split Date 3Nov 23, 2016

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 29, 2018
Most Recent Quarter (mrq)Jun 29, 2019

Profitability

Profit Margin 9.68%
Operating Margin (ttm)14.19%

Management Effectiveness

Return on Assets (ttm)18.01%
Return on Equity (ttm)26.78%

Income Statement

Revenue (ttm)1.12B
Revenue Per Share (ttm)47.42
Quarterly Revenue Growth (yoy)-15.10%
Gross Profit (ttm)988.54M
EBITDA 175.4M
Net Income Avi to Common (ttm)108.92M
Diluted EPS (ttm)4.50
Quarterly Earnings Growth (yoy)-37.00%

Balance Sheet

Total Cash (mrq)234.35M
Total Cash Per Share (mrq)10.53
Total Debt (mrq)19.43M
Total Debt/Equity (mrq)5.06
Current Ratio (mrq)2.71
Book Value Per Share (mrq)16.72

Cash Flow Statement

Operating Cash Flow (ttm)115.61M
Levered Free Cash Flow (ttm)100.77M